2025
SJR Q1
JCR Q2 · 3,8
OA
127 matched articles
SCIE
Journal detail
Journal of Inherited Metabolic Disease
- Publisher
- Springer Netherlands
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
0141895515732665
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,401
- Quartile Q1
- H-Index 131
- Cites/doc 3,85
- Docs (3y) 311
- Cites (3y) 1.201
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,8
- 5Y JIF 4,6
- JCI 0,83
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Genetics Q1
- Genetics (clinical) Q1
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,401 | 3,8 | 4,6 | 0,83 | Q2 | 131 |
| 2024 | Q1 | Q2 | 1,234 | 3,8 | 4,9 | 1,04 | Q1 | 125 |
| 2023 | Q1 | Q1 | 1,591 | 4,2 | 4,5 | 0,97 | Q2 | 125 |
| 2022 | Q1 | Q1 | 1,459 | 4,2 | 4,6 | 1,02 | Q1 | 125 |
| 2021 | Q1 | Q2 | 1,296 | 4,8 | 4,9 | 1,02 | Q1 | 125 |
| 2020 | Q1 | Q1 | 1,462 | 5 | 5,5 | 1,2 | Q1 | 125 |
| 2019 | Q2 | Q2 | 1,328 | 4 | 4,2 | 1,14 | Q1 | 125 |
| 2018 | — | Q1 | — | 4,3 | 4,3 | 1,33 | Q1 | — |
| 2017 | Q2 | Q1 | 1,668 | 4,1 | 4 | 1,21 | Q1 | 125 |
| 2016 | Q2 | Q1 | 1,574 | 4 | 3,7 | — | — | 125 |
| 2015 | Q2 | Q2 | 1,423 | 3,5 | 3,2 | — | — | 125 |
| 2014 | Q2 | Q2 | 1,307 | 3,4 | 2,7 | — | — | 125 |
| 2013 | Q2 | Q1 | 1,202 | 4,1 | 3,6 | — | — | 125 |
| 2012 | Q3 | Q1 | 0,845 | 4,1 | 3,4 | — | — | 125 |
| 2011 | Q3 | Q2 | 0,768 | 3,6 | 3,2 | — | — | 125 |
| 2010 | Q3 | Q2 | 0,871 | 3,8 | 3,2 | — | — | 125 |
| 2009 | — | Q2 | — | 3,6 | 2,5 | — | — | — |
| 2008 | — | Q2 | — | 2,7 | 2,1 | — | — | — |
| 2007 | — | Q3 | — | 1,7 | 1,8 | — | — | — |
| 2006 | — | Q3 | — | 1,6 | — | — | — | — |
| 2005 | — | Q3 | — | 1,7 | — | — | — | — |
| 2004 | — | Q3 | — | 1,6 | — | — | — | — |
| 2003 | — | Q3 | — | 1,8 | — | — | — | — |
| 2002 | — | Q3 | — | 1,6 | — | — | — | — |
| 2001 | — | Q3 | — | 1,8 | — | — | — | — |
| 2000 | — | Q3 | — | 1,3 | — | — | — | — |
| 1999 | — | Q3 | — | 1,6 | — | — | — | — |
| 1998 | — | Q3 | — | 1,4 | — | — | — | — |
| 1997 | — | Q3 | — | 1,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 77/198 |
| 2025 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 59/192 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 72/191 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 60/193 |
| 2024 | GENETICS & HEREDITY | SCIE | Q2 | Q1 | 49/192 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 66/195 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 40/186 |
| 2023 | GENETICS & HEREDITY | SCIE | Q1 | Q2 | 37/191 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 60/189 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 51/145 |
| 2022 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 41/171 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 63/136 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 52/146 |
| 2021 | GENETICS & HEREDITY | SCIE | Q2 | Q1 | 44/175 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 63/139 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 41/146 |
| 2020 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 40/176 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 49/140 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 38/143 |
| 2019 | GENETICS & HEREDITY | SCIE | Q2 | Q1 | 48/178 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 51/139 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 33/145 |
| 2018 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 36/174 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 38/136 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 33/142 |
| 2017 | GENETICS & HEREDITY | SCIE | Q1 | Q1 | 37/171 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 29/133 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 38/138 |
| 2016 | GENETICS & HEREDITY | SCIE | Q2 | — | 43/167 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 25/128 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 42/133 |
| 2015 | GENETICS & HEREDITY | SCIE | Q2 | — | 49/166 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 52/128 |
| 2014 | GENETICS & HEREDITY | SCIE | Q2 | — | 55/167 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 31/124 |
| 2013 | GENETICS & HEREDITY | SCIE | Q1 | — | 40/165 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 31/122 |
| 2012 | GENETICS & HEREDITY | SCIE | Q1 | — | 40/161 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 38/122 |
| 2011 | GENETICS & HEREDITY | SCIE | Q2 | — | 47/158 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 36/116 |
| 2010 | GENETICS & HEREDITY | SCIE | Q2 | — | 46/156 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 34/105 |
| 2009 | GENETICS & HEREDITY | SCIE | Q2 | — | 44/146 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 51/93 |
| 2008 | GENETICS & HEREDITY | SCIE | Q2 | — | 67/138 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 73/92 |
| 2007 | GENETICS & HEREDITY | SCIE | Q3 | — | 97/132 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 71/93 |
| 2006 | GENETICS & HEREDITY | SCIE | Q3 | — | 96/131 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 58/89 |
| 2005 | GENETICS & HEREDITY | SCIE | Q3 | — | 87/124 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 59/87 |
| 2004 | GENETICS & HEREDITY | SCIE | Q3 | — | 84/120 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 53/88 |
| 2003 | GENETICS & HEREDITY | SCIE | Q3 | — | 78/120 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 50/88 |
| 2002 | GENETICS & HEREDITY | SCIE | Q3 | — | 76/115 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 50/90 |
| 2001 | GENETICS & HEREDITY | SCIE | Q3 | — | 65/113 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 58/89 |
| 2000 | GENETICS & HEREDITY | SCIE | Q3 | — | 83/114 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 45/85 |
| 1999 | GENETICS & HEREDITY | SCIE | Q3 | — | 65/105 |
| 1998 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 47/83 |
| 1998 | GENETICS & HEREDITY | SCIE | Q3 | — | 61/103 |
| 1997 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 50/81 |
| 1997 | GENETICS & HEREDITY | SCIE | Q3 | — | 58/90 |